100 related articles for article (PubMed ID: 29803728)
21. Porphyromonas gulae Has Virulence and Immunological Characteristics Similar to Those of the Human Periodontal Pathogen Porphyromonas gingivalis.
Lenzo JC; O'Brien-Simpson NM; Orth RK; Mitchell HL; Dashper SG; Reynolds EC
Infect Immun; 2016 Sep; 84(9):2575-85. PubMed ID: 27354442
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of inflammatory mediator secretion by (-)-DHMEQ in mouse bone marrow-derived macrophages.
Suzuki E; Sugiyama C; Umezawa K
Biomed Pharmacother; 2009 Jun; 63(5):351-8. PubMed ID: 18635336
[TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of biotinylated DHMEQ for direct identification of its target NF-κB components.
Saitoh T; Takeiri M; Gotoh Y; Ishikawa Y; Umezawa K; Nishiyama S
Bioorg Med Chem Lett; 2011 Nov; 21(21):6293-6. PubMed ID: 21945203
[TBL] [Abstract][Full Text] [Related]
24. Anti-inflammatory activity of curcumin in macrophages stimulated by lipopolysaccharides from Porphyromonas gingivalis.
Chen D; Nie M; Fan MW; Bian Z
Pharmacology; 2008; 82(4):264-9. PubMed ID: 18849645
[TBL] [Abstract][Full Text] [Related]
25. PGE2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression.
Salvi GE; Beck JD; Offenbacher S
Ann Periodontol; 1998 Jul; 3(1):40-50. PubMed ID: 9722689
[TBL] [Abstract][Full Text] [Related]
26. Human β-defensin-2 and interleukin-1β expression in response to Porphyromonas gingivalis challenge in mice transplanted with periodontitic human gingiva.
Shimizu T; To M; Kamata Y; Saruta J; Sato T; Fuchida S; Hamada N; Tsukinoki K
Microb Pathog; 2017 Jun; 107():38-43. PubMed ID: 28286291
[TBL] [Abstract][Full Text] [Related]
27. Regulation of the NLRP3 inflammasome in Porphyromonas gingivalis-accelerated periodontal disease.
Yamaguchi Y; Kurita-Ochiai T; Kobayashi R; Suzuki T; Ando T
Inflamm Res; 2017 Jan; 66(1):59-65. PubMed ID: 27665233
[TBL] [Abstract][Full Text] [Related]
28. Can Better Management of Periodontal Disease Delay the Onset and Progression of Alzheimer's Disease?
Harding A; Robinson S; Crean S; Singhrao SK
J Alzheimers Dis; 2017; 58(2):337-348. PubMed ID: 28453484
[TBL] [Abstract][Full Text] [Related]
29. Consensus report. Periodontal diseases: pathogenesis and microbial factors.
Ann Periodontol; 1996 Nov; 1(1):926-32. PubMed ID: 9118284
[No Abstract] [Full Text] [Related]
30. Salivary infectious agents and periodontal disease status.
Saygun I; Nizam N; Keskiner I; Bal V; Kubar A; Açıkel C; Serdar M; Slots J
J Periodontal Res; 2011 Apr; 46(2):235-9. PubMed ID: 21261620
[TBL] [Abstract][Full Text] [Related]
31. SOCS-3 Regulates Alveolar Bone Loss in Experimental Periodontitis.
Papathanasiou E; Kantarci A; Konstantinidis A; Gao H; Van Dyke TE
J Dent Res; 2016 Aug; 95(9):1018-25. PubMed ID: 27126447
[TBL] [Abstract][Full Text] [Related]
32. Antibacterial, antiadherence, antiprotease, and anti-inflammatory activities of various tea extracts: potential benefits for periodontal diseases.
Zhao L; La VD; Grenier D
J Med Food; 2013 May; 16(5):428-36. PubMed ID: 23631500
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the host response in various models of induced periodontal disease in mice.
de Molon RS; de Avila ED; Boas Nogueira AV; Chaves de Souza JA; Avila-Campos MJ; de Andrade CR; Cirelli JA
J Periodontol; 2014 Mar; 85(3):465-77. PubMed ID: 23805811
[TBL] [Abstract][Full Text] [Related]
34. Novel cyclic compounds as potent phosphodiesterase 4 inhibitors.
He W; Huang FC; Hanney B; Souness J; Miller B; Liang G; Mason J; Djuric S
J Med Chem; 1998 Oct; 41(22):4216-23. PubMed ID: 9784096
[TBL] [Abstract][Full Text] [Related]
35. Oral administration of Lactobacillus gasseri SBT2055 is effective in preventing Porphyromonas gingivalis-accelerated periodontal disease.
Kobayashi R; Kobayashi T; Sakai F; Hosoya T; Yamamoto M; Kurita-Ochiai T
Sci Rep; 2017 Apr; 7(1):545. PubMed ID: 28373699
[TBL] [Abstract][Full Text] [Related]
36. CXCR4 signaling in macrophages contributes to periodontal mechanical hypersensitivity in Porphyromonas gingivalis-induced periodontitis in mice.
Nagashima H; Shinoda M; Honda K; Kamio N; Watanabe M; Suzuki T; Sugano N; Sato S; Iwata K
Mol Pain; 2017 Jan; 13():1744806916689269. PubMed ID: 28326928
[TBL] [Abstract][Full Text] [Related]
37. Cranberry proanthocyanidins act in synergy with licochalcone A to reduce Porphyromonas gingivalis growth and virulence properties, and to suppress cytokine secretion by macrophages.
Feldman M; Grenier D
J Appl Microbiol; 2012 Aug; 113(2):438-47. PubMed ID: 22563853
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and cytotoxic activity of C-glycosidic nicotinamide riboside analogues.
Krohn K; Heins H; Wielckens K
J Med Chem; 1992 Feb; 35(3):511-7. PubMed ID: 1738143
[TBL] [Abstract][Full Text] [Related]
39. 1-Tetradecanol complex reduces progression of Porphyromonas gingivalis-induced experimental periodontitis in rabbits.
Hasturk H; Jones VL; Andry C; Kantarci A
J Periodontol; 2007 May; 78(5):924-32. PubMed ID: 17470028
[TBL] [Abstract][Full Text] [Related]
40. TLR4, NOD1 and NOD2 mediate immune recognition of putative newly identified periodontal pathogens.
Marchesan J; Jiao Y; Schaff RA; Hao J; Morelli T; Kinney JS; Gerow E; Sheridan R; Rodrigues V; Paster BJ; Inohara N; Giannobile WV
Mol Oral Microbiol; 2016 Jun; 31(3):243-258. PubMed ID: 26177212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
